Yrreb Oral Drops contain Vitamin D3 (200 IU) as the active ingredient, essential for maintaining optimal bone health and calcium homeostasis. This formulation is indicated for the prevention and treatment of Vitamin D deficiency and insufficiency, which can lead to conditions such as rickets in children and osteomalacia or osteoporosis in adults. Vitamin D3 facilitates the intestinal absorption of calcium and phosphate, thereby supporting proper bone mineralization and skeletal development. Yrreb Oral Drops are particularly beneficial for individuals with limited sun exposure, malabsorption syndromes, or increased physiological demands such as pregnancy and lactation. The oral drop formulation allows for precise dosing and ease of administration, making it suitable for pediatric and adult patients. It is recommended to use this product under medical supervision to ensure appropriate dosage and to avoid hypervitaminosis D, which may result in hypercalcemia and associated complications. Patients with hypersensitivity to Vitamin D3 or any excipients should avoid this medication. Regular monitoring of serum calcium and Vitamin D levels is advised during prolonged therapy. Yrreb Oral Drops should be stored in a cool, dry place away from direct sunlight and out of reach of children.